Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
BridgeBio Pharma’s heart disease drug meets main goal in late-stage study
The company said no safety concerns were identified in patients, adding that it intends t submit marketing applications to the US…
Enteric delivery of my API: how to make it right? | 31st July 2023
31st July 2023 | Live Webinar | 3:00 PM - 4:00 PM IST
Zeon Lifesciences launches liquid-filled capsules
Zeon has partnered with collaborative third-party manufacturing for liquid filled capsules
Sathgen Therapeutics announces completion of first cohort in phase 1 clinical trial with anti-cancer…
Sathgen aims to develop MSP008-22 for difficult-to-treat cancers, starting with triple negative breast cancer (TNBC) and prostate…
Lupin receives USFDA approval for Chlorpromazine Hydrochloride tablets
This product will be manufactured at Lupin’s Somerset facility in the U.S.
Atrial fibrillation market to decline during 2022-32: GlobalData
GlobalData’s report, “Atrial Fibrillation: Eight Market Drug Forecast and Market Analysis,” reveals that five late-stage pipeline…
EMA accepts Intas Pharma’s MAA for DMB-3115
herapeutic equivalence and safety confirmed between DMB-3115 and Stelara in global phase III
Nutrizoe raises Rs 3 Cr in bridge round
The funds will be utiliaed for expanding the Lactobite portfolio after conducting clinical trials, exploring export opportunities…
DCO(I) WA’s 1st annual congress concludes successfully
The interactive sessions provided valuable insights and opportunities for skill development
SII’s MenFive receives WHO prequalification
MenFive is currently undergoing an additional Phase 3 study in healthy children between 9 and 15 months of age in Mali, to examine…